Initiated Phase 2 STRIDES trial of azelaprag in combination with tirzepatide for obesityCompleted $238.3 million initial public offering and ...

Not only are deals going off at higher valuations than the companies initially anticipated, but the prices have been popping after the stocks began trading in the public markets. Observers are hoping ...

Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount ...

The IPO will open for bids from Nov. 6 to Nov. 9, and shares are expected to start trading from Nov. 13, according to the red herring prospectus published Tuesday. Anchor investors can put in ...

Lulu Retail on Monday set an offer price between Dh1.94 and Dh2.04 per share for its initial public offering (IPO), implying a market capitalization of Dh20.04 billion and Dh21.07 billion.

Godavari Biorefineries IPO allotment date is likely today, October 28, and the company is expected to fix the basis of share allotment soon. (Photo: Company Website) Godavari Biorefineries IPO ...

The U.S. IPO pipeline is slowing down ahead of the U.S. presidential elections on November 5th, while investors continue to sift through the plethora of corporate earnings as they gauge the state ...

Waaree Energies IPO Listing: After receiving record-breaking response from investors for its initial public offering (IPO), the equity shares of solar PV modules manufacturer Waaree Energies Ltd ...

US cybersecurity startup Armis said Monday that it’s preparing for an initial public offering in 2026 after closing a $200 million funding round that valued it at $4.2 billion. Armis’s latest ...

2024 Weight-loss drug developer BioAge raises $198 mln in U.S. IPO September 26, 2024 Obesity drug developer BioAge Labs aims up to $640 mln valuation in upsized US IPO September 25, 2024 Obesity ...

Drug developers have achieved resounding success in the fall U.S. IPO market, with all the $100-million plus offerings since September upsized. Robust debuts by drug developers Bicara Therapeutics , ...